Pages that link to "Q48483333"
Jump to navigation
Jump to search
The following pages link to Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose (Q48483333):
Displaying 50 items.
- High intensity exercise decreases global brain glucose uptake in humans (Q24547219) (← links)
- Neuroimaging and drug taking in primates (Q24631230) (← links)
- Applications of 2-deoxy-2-fluoro-D-glucose (FDG) in Plant Imaging: Past, Present, and Future (Q26744615) (← links)
- Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies (Q26777636) (← links)
- Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder (Q27015917) (← links)
- Regional differences in the coupling between resting cerebral blood flow and metabolism may indicate action preparedness as a default state (Q30228891) (← links)
- Monoamine transporter inhibitors and substrates as treatments for stimulant abuse (Q30413718) (← links)
- FDG-PET imaging in mild traumatic brain injury: a critical review (Q30730474) (← links)
- The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation (Q31970408) (← links)
- Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer (Q33369337) (← links)
- Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction (Q33383360) (← links)
- Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia (Q33621605) (← links)
- Dominantly inherited Alzheimer's disease: cerebral glucose metabolism (Q33628634) (← links)
- Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET. (Q33733410) (← links)
- Methodological considerations in quantification of oncological FDG PET studies. (Q33915164) (← links)
- Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET). (Q33944002) (← links)
- Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors (Q33995787) (← links)
- Association between serial dynamic contrast‐enhanced MRI and dynamic 18F‐FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer (Q34257646) (← links)
- Brain metabolism during short-term starvation in humans (Q34346503) (← links)
- Dynamic functional imaging of brain glucose utilization using fPET-FDG. (Q34425194) (← links)
- Systemic chemotherapy decreases brain glucose metabolism (Q34562855) (← links)
- Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury (Q34727149) (← links)
- [F]fluoro-2-deoxy-d-glucose incorporation by mcf-7 breast tumour cells in vitro is modulated by treatment with tamoxifen, Doxorubicin, and docetaxel: relationship to chemotherapy-induced changes in ATP content, hexokinase activity, and glucose trans (Q34730079) (← links)
- PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake. (Q34914187) (← links)
- Energy metabolism and selective neuronal vulnerability following global cerebral ischemia. (Q35407013) (← links)
- Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II) (Q36215997) (← links)
- Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism (Q36277213) (← links)
- Positron emission tomography imaging of regional cerebral glucose metabolism (Q36418573) (← links)
- Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study (Q36446335) (← links)
- Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas (Q36621241) (← links)
- Current and future use of positron emission tomography (PET) in breast cancer (Q36639914) (← links)
- Brain-Behavior Relationships in Aphasia Studied by Positron Emission Tomography (Q36650507) (← links)
- Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints (Q36661066) (← links)
- Morning-evening variation in human brain metabolism and memory circuits (Q36700360) (← links)
- Hippocampal hypometabolism predicts cognitive decline from normal aging (Q36725261) (← links)
- The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle (Q36804318) (← links)
- Increased interictal cerebral glucose metabolism in a cortical-subcortical network in drug naive patients with cryptogenic temporal lobe epilepsy (Q36882637) (← links)
- Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci (Q36976572) (← links)
- Crossed aphasia: a PET follow up study of two cases (Q36976798) (← links)
- The MAO-A genotype does not modulate resting brain metabolism in adults (Q37001214) (← links)
- Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetes (Q37031004) (← links)
- Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease (Q37180524) (← links)
- Inverse association between BMI and prefrontal metabolic activity in healthy adults (Q37189405) (← links)
- Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF. (Q37217533) (← links)
- Unidirectional Influx and Net Accumulation of PIB (Q37225494) (← links)
- FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease (Q37415324) (← links)
- Usefulness of additional delayed regional F-18 Fluorodeoxy-Glucose Positron Emission Tomography in the lymph node staging of Non-Small Cell Lung Cancer patients (Q37446915) (← links)
- PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain. (Q37695347) (← links)
- PET/CT and vascular disease: Current concepts (Q37849421) (← links)
- Vascular imaging with positron emission tomography. (Q37868709) (← links)